Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.47NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.182NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.182NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.182NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.218NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.218NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.218NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.12.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.12.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.12.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.22 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.22 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.22 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.128NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.128NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.128NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.33NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.33NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.405NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.405NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.405NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.296NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.296NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.296NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.412NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.412NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.412NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AC.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AC.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AC.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.27NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.27NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.421NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-17944.4US
B.1.1.421NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.421NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16604.2China
B.1.1.364NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.364NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.364NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.82NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.82NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.82NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.61NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.61NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.61NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.47NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used